Systemic nerve and muscle disease Flashcards
Peripheral Polyneuropaties - how to characterize
- acute or gradual onset (e.g. GBS/AIDP v DM PN)
- demyelinating or primarily axonal (e.g., decreased CV, increased latency, +/- CB; or decreased amplitude); or both
- sensor, motor, or both
- diffuse and symmetric or mutlifocal and asymmetric
most are symmetric and symptomatically/electrodiagnostically worse distally
DM PN - pathophysiology, Px, PE
most common form of PN
Hx elevated A1C and poor blood glucose control → narrowing ov vasa nevorum → length-dependent dying back of PNs (axonal loss)
Px: gradual onset numbness/tingling w burning pain in stocking and glove distribution
PE: claw toes and hand muscle atrophy, areflexic achilles reflexes
DM PN - NCS/EMG
primarily axonal (dying back of n) → decreased amplitude
NCS: decreased amplitude on SNAP/CMAPs; may have prolonged latency if demyelinating component (CB, temporal dispersion)
EMG: if axonal process (dying back) → decreased recruitment distal > proximal; polyphasicity (reinnervation)
findings typically symmetric
evaluate at least 3 limbs
GBS/AIDP - pathophysiology, Px, concerns, Tx
recent GI/respiratory infection → rapidly progressive motor polyneuropathy d/t immune system confusing myelin for foreign protein → acute onset ascending paralysis (e.g., over days) with ascending areflexia
quick Dx → quick Tx (IVIG/plasmapheresis) → better prognosis; concern for respiratory compromise
GBS/AIDP - NCS
NCS: 1st change is absent or delayed F waves; H reflexes may also become abnormal early on
abnormal F and H waves → suggests proximal lesion e.g., polyradiculopathy
demyelinating process
SNAP: prolonged latency, reduced amplitude w sural sparing (sural n. large w more myelin than median/ulnar)
CMAP: prolonged latency, decreased CV, +/- CB w abnormal temporal dispersion; usually amplitude is normal
GBS/AIDP - key prognostic factor on NCS
if distal CMAP amplitude is <20% upper limit of normal → bad prognosis
demyelination so severe that axonal loss is ocurring
GBS/AIDP - EMG
mainly demyelinating process → normal EMG if no axonal loss has taken place
if severe w lots of CB → decreased recruitment
several weeks after onset → may see fibs/sharps (active denervation) d/t secondary axonal loss
CIDP v AIDP
CIDP essentially relapsing-remitting AIDP
Px and EDS findings similar except symptom progression is much slower (months)
Tx: plasmapheresis, IVIG, steroids (unlike AIDP)
critical illness neuropathy EDX
axonal sensorimotor polyneuropathy following critical illness, Tx rehab
NCS: abnormal SNAPs and CMAPs (low amplitude d/t axonal loss)
EMG: LDLA (long duration, large amplitude), decreased recruitment (machine gun), fibs/sharps
few axons → fewer motor units doing all the work for muscle contraction
CMT etiology px
many subtypes; duplication of PMP 22 gene
gradual distal > proximal weakness, fewer sensory abnormalities
b/l foot drop, Champagne bottle legs d/t calf and anterior compartment muscle wasting → weak dorsiflexion
deletion of PMP 22 gene
gives HNPP - hereditary neuropathy with liability to pressure palsy
CMT 2
gives you axonal polyneuropathy → EDX: decreased amplitude SNAPs/CMAPs; active denervation/reinnervation on EMG
CMT 1
demyelinating → EDX prolonged latency, decreased CV, without conduction block or abnormal temporal dispersion
usually uniform demyelination w CMT
AIDP v CMT 1 EDX
CMT 1 demyelinating - uniformly therefore universally prolonged latency and decreased CV (without conduction block or abnormal temporal dispersion)
v AIDP - focal demyelination → conduction block at normally non entrapment sites
HIV neuropathy
polyneuropathy
typically distal axonal
symmetric
sensory > motor
NCS: abnormal amplitudes of SNAPs/CMAPs
EMG: abnormal spontaneous activity in distal > proximal muscles